Adult Onset Still's Disease

Erdheim–Chester disease
Montserrat Juanós-Iborra, Javier Solanich-Moreno, Albert Selva-O'Callaghan

Annals of the Rheumatic Diseases Jun 2013, 72 (6) e10; DOI: 10.1136/annrheumdis-2013-203519
Response to comments in: Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study by Clockaerts et al
Daniel L Riddle, George Moxley, Levent Dumenci

Annals of the Rheumatic Diseases Jun 2013, 72 (6) e12; DOI: 10.1136/annrheumdis-2013-203546
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
Claire-Louise Murphy, Eithne Murphy, Trevor Duffy, Miriam O'Sullivan, Maurice Barry

Annals of the Rheumatic Diseases Jun 2013, 72 (6) e13; DOI: 10.1136/annrheumdis-2013-203637
Canakinumab for Treatment of Adult-Onset Still’s Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
Claudia Kedor, Joachim Listing, Jan Zernicke, Anja Weiß, Frank Behrens, Norbert Blank, Joerg Christoph Henes, Joern Kekow, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Eva Seipelt, Christof Specker, Eugen Feist

Annals of the Rheumatic Diseases Aug 2020, 79 (8) 1090-1097; DOI: 10.1136/annrheumdis-2020-217155
Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences
H G Kraetsch, C Antoni, J R Kalden, B Manger

Annals of the Rheumatic Diseases Nov 2001, 60 (suppl 3) iii55-iii57; DOI: 10.1136/ard.60.90003.iii55
Application of MS score in macrophage activation syndrome patients associated with adult onset Still’s disease
Ran Wang, Ting Li, Shuang Ye, Wenefng Tan, Cheng Zhao, Yisha Li, Chunde Bao, Qiong Fu

Annals of the Rheumatic Diseases Sep 2021, 80 (9) e145; DOI: 10.1136/annrheumdis-2019-216286
Response to ‘Application of MS score in macrophage activation syndrome patients associated with adult onset Still’s disease’ by Wang et al
Francesca Minoia, Angelo Ravelli

Annals of the Rheumatic Diseases Sep 2021, 80 (9) e146; DOI: 10.1136/annrheumdis-2019-216310
Response to: ‘Tocilizumab in patients with adult-onset Still’s disease refractory to glucocorticoid treatment’ by Lee
Yuko Kaneko, Hideto Kameda, Kei Ikeda, Tomonori Ishii, Kosaku Murakami, Hyota Takamatsu, Yoshiya Tanaka, Takayuki Abe, Tsutomu Takeuchi

Annals of the Rheumatic Diseases Dec 2019, 78 (12) e134; DOI: 10.1136/annrheumdis-2018-214653
Tocilizumab in patients with adult-onset Still’s disease refractory to glucocorticoid treatment
Young Ho Lee

Annals of the Rheumatic Diseases Dec 2019, 78 (12) e133; DOI: 10.1136/annrheumdis-2018-214635
Tofacitinib in refractory adult-onset Still’s disease: 14 cases from a single centre in China
Qiongyi Hu, Mengyan Wang, Jinchao Jia, Jialin Teng, Huihui Chi, Tingting Liu, Hong-lei Liu, Xiaobing Cheng, Junna Ye, Yutong Su, Yue Sun, Zhuochao Zhou, Liyan Wan, Zhihong Wang, Fan Wang, Hui Shi, Chengde Yang

Annals of the Rheumatic Diseases Jun 2020, 79 (6) 842-844; DOI: 10.1136/annrheumdis-2019-216699

Main menu

Adult Onset Still's Disease

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Adult Onset Still's Disease

Pages